The economic burden of animal diseases is recognized to be substantial. Disease characteristics, the susceptibility of animal populations and environmental factors determine rates of infection, mortality, and impacts on productivity in animals and may directly, in the case of zoonoses,1 affect human health (Rushton et al. 2018). Meanwhile, loss of livestock, trade, decreased market value, food insecurity, environmental impacts, and efforts to respond to animal diseases all come at considerable costs to livelihoods and both public and private sector interests (Barratt et al. 2019). Endemic and emerging transboundary animal diseases (TADs) threaten livestock producers in Asia, hampering livestock productivity, causing market disruptions, and inhibiting formal trade production animals and products. Knight-Jones and Rushton (2013) estimated the global costs of foot-and-mouth disease (FMD) alone to be $21 billion.